Comprehensive medication guide to Nitro-Dur including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$20 copay/month for generic nitroglycerin patches on most commercial and Medicare Part D plans (typically Tier 1–2); brand-name Nitro-Dur may be Tier 3–4 with a higher copay or prior authorization requirement.
Estimated Cash Pricing
$20–$60/month at retail for generic nitroglycerin transdermal patches; brand-name Nitro-Dur can retail for $100–$200+/month. With GoodRx or SingleCare discount coupons, generic patches typically cost $15–$40 for a 30-day supply.
Medfinder Findability Score
68/100
Summarize with AI
On this page
Nitro-Dur is the brand name for nitroglycerin transdermal patches — a skin patch applied once daily to prevent chest pain (angina) in people with coronary artery disease. The patch releases nitroglycerin steadily into the bloodstream over 12 to 14 hours, providing continuous angina prevention without multiple daily doses.
Nitroglycerin is an organic nitrate and vasodilator — one of the oldest and most established cardiac medications. It's available in multiple forms including sublingual tablets and sprays for acute angina, but the transdermal patch is the standard long-term preventive formulation. Generic equivalents include Minitran, Nitro TD Patch-A, and various generic nitroglycerin transdermal systems.
Nitro-Dur patches come in six dose strengths measured in mg/hr (amount delivered per hour): 0.1, 0.2, 0.3, 0.4, 0.6, and 0.8 mg/hr. The most commonly prescribed starting doses are 0.2 mg/hr and 0.4 mg/hr. Each patch is worn for 12–14 hours, followed by a 10–12 hour patch-free period to prevent tolerance.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Nitro-Dur delivers nitroglycerin through the skin at a controlled rate. Once absorbed into the bloodstream, nitroglycerin is converted to nitric oxide (NO) — a signaling molecule that relaxes smooth muscle cells in blood vessel walls, causing vasodilation (widening of blood vessels).
Nitroglycerin preferentially dilates veins, reducing the amount of blood returning to the heart (preload reduction). It also dilates arteries, reducing the resistance the heart pumps against (afterload reduction). Coronary arteries are also dilated, improving blood supply to the heart muscle itself. These combined effects lower the heart's oxygen demand while improving supply.
The patch-free interval of 10–12 hours daily is essential: continuous nitroglycerin exposure causes the blood vessels to become tolerant within 24 hours, rendering the medication ineffective. The daily break prevents this tolerance from developing, maintaining consistent efficacy.
0.1 mg/hr — transdermal patch
Lowest available dose; occasionally used for initial titration
0.2 mg/hr — transdermal patch
Common starting dose for angina prevention
0.3 mg/hr — transdermal patch
Intermediate dose
0.4 mg/hr — transdermal patch
Common starting and maintenance dose; delivers up to 0.4 mg/hr
0.6 mg/hr — transdermal patch
Higher maintenance dose for patients requiring greater angina control
0.8 mg/hr — transdermal patch
Highest available dose for significant angina burden
Nitro-Dur transdermal patches are generally available at most major pharmacies, though patients occasionally encounter localized stock-outs. The broader nitroglycerin supply chain has faced more significant challenges with sublingual tablets (Nitrostat) and injectable forms — the transdermal patch category has been relatively less affected.
When availability issues occur, they tend to be localized to individual pharmacies running out between restocking cycles rather than national shortages. Specific dose strengths (particularly 0.4 mg/hr) may sometimes be harder to find than others. Independent pharmacies often have stock when chains don't, due to different wholesale supplier relationships.
If you're having trouble filling your Nitro-Dur prescription, medfinder contacts pharmacies near you to find which ones have your medication in stock — saving you hours of phone calls and helping ensure you don't miss doses of this important cardiac medication.
Because Nitro-Dur is not a controlled substance, it can be prescribed by any licensed healthcare provider with standard prescriptive authority — no special DEA licensing is required. Nitro-Dur is typically prescribed in the context of a diagnosed coronary artery disease management plan.
Cardiologists — Primary specialists who manage coronary artery disease and initiate long-acting nitrate therapy
Primary care physicians (family medicine, internal medicine) — Frequently manage stable CAD and prescribe/refill Nitro-Dur
Internists — Routinely prescribe for cardiac conditions
Nurse practitioners (NPs) and physician assistants (PAs) — Can prescribe in most states, often in collaboration with supervising physicians
Telehealth providers can prescribe Nitro-Dur for established patients with documented coronary artery disease, making it accessible via cardiac telehealth services for refills and ongoing management. New diagnoses typically require an in-person cardiac evaluation before initiating therapy.
No. Nitro-Dur (nitroglycerin transdermal patch) is not a federally controlled substance under DEA scheduling. It is not classified under Schedule I, II, III, IV, or V of the Controlled Substances Act.
Because nitroglycerin is not a controlled substance, there are no special DEA prescribing requirements, no limits on refill quantity, and no mandatory prescription monitoring program (PMP) reporting. Any licensed prescriber with standard prescriptive authority — including physicians, nurse practitioners, and physician assistants — can prescribe Nitro-Dur without special DEA authorization.
However, nitroglycerin does require a valid prescription — it is not available over the counter. This is due to its clinical indication (coronary artery disease) and the important drug interactions and safety considerations requiring medical oversight.
The most frequently reported side effects are dose-related and result from nitroglycerin's vasodilatory mechanism:
Headache — Most common; often a sign the medication is working. Usually improves within 1–2 weeks.
Dizziness and lightheadedness — Especially when rising from sitting or lying positions. Rise slowly to minimize this effect.
Flushing — Warmth or redness of the face and upper body.
Application site irritation — Redness, itching, or mild rash at the patch site. Rotate sites daily.
Orthostatic hypotension — Blood pressure drop upon standing, especially in elderly or dehydrated patients.
Severe hypotension — Particularly dangerous in combination with PDE-5 inhibitors; can cause syncope and cardiovascular collapse.
Syncope (fainting) — Seek emergency care if this occurs.
Anaphylaxis — Rare; remove patch immediately and call 911 if signs of allergic reaction occur.
Methemoglobinemia — Very rare; indicated by blue-colored lips/skin, weakness, and shortness of breath.
Worsening angina — May occur in patients with hypertrophic cardiomyopathy; discontinue and contact provider.
Know what you need? Skip the search.
Isosorbide Mononitrate (Imdur)
Oral long-acting nitrate taken once daily; same drug class as nitroglycerin; widely available as generic at $10–$30/month; requires asymmetric dosing to maintain nitrate-free interval.
Isosorbide Dinitrate (Isordil)
Shorter-acting oral nitrate; taken 2–3 times daily with nitrate-free period; long-established alternative for chronic angina prevention.
Metoprolol Succinate (Toprol-XL)
Beta-blocker; first-line antianginal that reduces heart rate and oxygen demand; often used in combination with nitrates; widely available as generic.
Amlodipine (Norvasc)
Calcium channel blocker used for angina and hypertension; alternative for patients who cannot tolerate beta-blockers; available as inexpensive generic.
Prefer Nitro-Dur? We can find it.
Sildenafil (Viagra/Revatio)
majorCONTRAINDICATED: Additive vasodilation causing severe, potentially fatal hypotension. Absolute contraindication — do not combine under any circumstances.
Tadalafil (Cialis/Adcirca)
majorCONTRAINDICATED: Same mechanism as sildenafil; risk of severe, life-threatening hypotension. Absolute contraindication.
Vardenafil (Levitra/Staxyn)
majorCONTRAINDICATED: PDE-5 inhibitor causing severe hypotension in combination with nitroglycerin. Absolute contraindication.
Avanafil (Stendra)
majorCONTRAINDICATED: PDE-5 inhibitor; risk of severe hypotension. Absolute contraindication.
Riociguat (Adempas)
majorCONTRAINDICATED: Soluble guanylate cyclase stimulator causing severe hypotension in combination with nitroglycerin.
Ergotamine / Dihydroergotamine (DHE)
majorCONTRAINDICATED: Ergot alkaloids counteract nitroglycerin's vasodilatory effects and can worsen angina.
Antihypertensives (beta-blockers, CCBs, ACE inhibitors, ARBs)
moderateAdditive blood-pressure-lowering effects. Moderate interaction — monitor blood pressure; dose adjustments may be needed.
Alcohol
moderateAdditive vasodilatory effects causing increased dizziness, lightheadedness, and hypotension risk. Limit alcohol intake.
Diuretics
moderateAdditive blood pressure reduction; dehydration amplifies hypotensive effects. Monitor blood pressure and hydration status.
Nitro-Dur is a cornerstone medication for millions of Americans managing coronary artery disease and chronic angina. When used correctly — applied daily for 12–14 hours with a mandatory patch-free interval — it provides reliable, long-term angina prevention at a cost that is manageable with generic substitution and prescription discount programs.
The most critical safety consideration is the absolute contraindication with PDE-5 inhibitors (Viagra, Cialis, Levitra, Stendra) — a combination that can be life-threatening. Every patient on Nitro-Dur should carry a list of their medications and proactively inform every provider and pharmacist they encounter.
If you're struggling to find Nitro-Dur at your local pharmacy, medfinder can help. medfinder contacts pharmacies in your area to find which ones have your medication in stock — saving you time and ensuring you don't miss doses of this important cardiac medication.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards